TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 165 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $12,000 | -25.0% | 244 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -11.1% | 244 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $18,000 | 0.0% | 244 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $18,000 | 0.0% | 244 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $18,000 | +38.5% | 244 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $13,000 | -18.8% | 244 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $16,000 | +6.7% | 244 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $15,000 | -28.6% | 244 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $21,000 | +16.7% | 244 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $18,000 | -14.3% | 244 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $21,000 | -19.2% | 244 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $26,000 | +23.8% | 244 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $21,000 | -12.5% | 244 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $24,000 | -14.3% | 244 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $28,000 | +16.7% | 244 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $24,000 | -7.7% | 244 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $26,000 | -13.3% | 244 | -7.2% | 0.00% | 0.0% |
| Q3 2017 | $30,000 | +3.4% | 263 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $29,000 | -6.5% | 263 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $31,000 | +10.7% | 263 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $28,000 | -3.4% | 263 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $29,000 | -23.7% | 263 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $38,000 | 0.0% | 263 | 0.0% | 0.01% | +16.7% |
| Q1 2016 | $38,000 | -7.3% | 263 | 0.0% | 0.01% | -14.3% |
| Q4 2015 | $41,000 | +7.9% | 263 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $38,000 | +2.7% | 263 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $37,000 | -5.1% | 263 | 0.0% | 0.01% | -22.2% |
| Q4 2014 | $39,000 | -15.2% | 263 | -12.3% | 0.01% | -18.2% |
| Q3 2014 | $46,000 | +7.0% | 300 | 0.0% | 0.01% | +10.0% |
| Q2 2014 | $43,000 | +30.3% | 300 | 0.0% | 0.01% | +25.0% |
| Q1 2014 | $33,000 | +10.0% | 300 | 0.0% | 0.01% | +14.3% |
| Q4 2013 | $30,000 | -3.2% | 300 | -25.0% | 0.01% | -22.2% |
| Q3 2013 | $31,000 | +34.8% | 400 | 0.0% | 0.01% | +28.6% |
| Q2 2013 | $23,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |